Thyroid Cancer

Latest

Rates of Lobectomy vs Thyroidectomy for Low-Risk Differentiated Thyroid Cancer

Rates of Lobectomy vs Thyroidectomy for Low-Risk Differentiated Thyroid Cancer

Adherence to the 2015 recommendation from ATA — to use lobectomy rather than complete thyroidectomy for low-risk differentiated thyroid cancer — is increasing.

Childhood Radiation-Induced Thyroid Cancer Does Not Lower All-Cause Survival

Childhood Radiation-Induced Thyroid Cancer Does Not Lower All-Cause Survival

Childhood radiation-induced thyroid cancer does not affect all-cause mortality compared with healthy individuals.

Malignancy Rates Higher in Children With Indeterminate Thyroid Nodules

Malignancy Rates Higher in Children With Indeterminate Thyroid Nodules

Malignancy was more common in children with thyroid nodules classified as indeterminate by BSRTC criteria compared with adults.

BABA Robotic Thyroidectomy Determined to Be Safe and Effective

BABA Robotic Thyroidectomy Determined to Be Safe and Effective

The BABA robotic thyroidectomy technique appears to be safe, with excellent outcomes in benign and malignant thyroid disease.

Ethanol Sensitization May Improve RFA of Benign Thyroid Nodules

Ethanol Sensitization May Improve RFA of Benign Thyroid Nodules

Ethanol sensitization before radiofrequency ablation of benign thyroid nodules reduced time, ablation energy, and complications compared with conventional ablation.

Recombinant Human Thyrotropin vs Thyroid Hormone Withdrawal After Radioiodine Therapy in Thyroid Cancer

Recombinant Human Thyrotropin vs Thyroid Hormone Withdrawal After Radioiodine Therapy in Thyroid Cancer

Outcomes after radioiodine therapy are similar after preparation with either recombinant human thyrotropin or thyroid hormone withdrawal.

US Centers Fail to Analyze Neck Lymph Nodes in Preoperative Ultrasounds for Thyroid Cancer

US Centers Fail to Analyze Neck Lymph Nodes in Preoperative Ultrasounds for Thyroid Cancer

Most imaging centers in the United States fail to analyze lateral neck lymph nodes during preoperative ultrasounds in patients with thyroid cancer.

Male Thyroid Cancer Survivors Face Higher CVD Risk

Male Thyroid Cancer Survivors Face Higher CVD Risk

Male thyroid cancer survivors have a nearly 50 percent higher risk of developing CVD than female survivors within five years of cancer diagnosis.

RET Inhibitor Gets Breakthrough Treatment Status for Medullary Thyroid Cancer

RET Inhibitor Gets Breakthrough Treatment Status for Medullary Thyroid Cancer

LOXO-292 is being evaluated in the ongoing Phase 1/2 LIBRETTO-001 clinical trial.

Wording Used May Affect Thyroid Cancer Patients' Anxiety, Choices

Wording Used May Affect Thyroid Cancer Patients' Anxiety, Choices

Calling it 'cancer' rather than 'lesions' or 'abnormal cells' could increase anxiety, likelihood of surgery.

Sign Up for Free e-Newsletters



CME Focus